B

Baroness Merron (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

The noble Baroness raises an important point, and I can give her that assurance. The focus on menopause is a key part of the women’s health strategy which we published earlier this year. On her point about clinicians, I am sure she will be pleased to know that, just last month, we introduced a new and updated medical licensing assessment. Anyone graduating from medical school is required to pass that, which means that they will have a better understanding. We are also developing a range of tools and interventions to support existing GPs to upskill. I am sure that the noble Baroness will welcome the fact that we are, for the first time ever, introducing menopause into NHS health checks.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.